RP

Robert C. Pordy

RP Regeneron Pharmaceuticals: 10 patents #119 of 810Top 15%
SB Sanofi Biotechnology: 3 patents #13 of 74Top 20%
📍 Ardsley, NY: #21 of 90 inventorsTop 25%
🗺 New York: #14,659 of 115,490 inventorsTop 15%
Overall (All Time): #487,892 of 4,157,543Top 15%
10
Patents All Time

Issued Patents All Time

Showing 1–10 of 10 patents

Patent #TitleCo-InventorsDate
12029788 Methods for increasing lean body mass with an exercise regimen and a GDF8 inhibitor that is an anti-GDF8 antibody Xiaobing Qian, Stephen Donahue 2024-07-09
11904017 Methods for reducing or eliminating the need for lipoprotein apheresis in patients with hyperlipidemia by administering alirocumab Garen Manvelian 2024-02-20
11306155 Methods for treating patients with heterozygous familial hypercholesterolemia (heFH) with an anti-PCSK9 antibody Marie Baccara-Dinet, Corinne Hanotin, Laurence Bessac, Umesh Chaudhari, William J. Sasiela +1 more 2022-04-19
11248044 Methods for altering body composition by administering a GDF8 inhibitor and an Activin A inhibitor Stephen Donahue, Gary Herman 2022-02-15
10934349 Methods for increasing lean body mass with resistance training and a GDF8 inhibitor that is an anti-GDF8 antibody Xiaobing Qian, Stephen Donahue 2021-03-02
10772956 Methods for reducing or eliminating the need for lipoprotein apheresis in patients with hyperlipidemia by administering alirocumab Garen Manvelian 2020-09-15
10544232 Methods for treating patients with heterozygous familial hypercholesterolemia (heFH) with an anti-PCSK9 antibody Marie Baccara-Dinet, Corinne Hanotin, Laurence Bessac, Umesh Chaudhari, William J. Sasiela +1 more 2020-01-28
10428157 Dosing regimens for use with PCSK9 inhibitors Marie Baccara-Dinet, Laurence Bessac, Corinne Hanotin, William J. Sasiela, Jacques Rey 2019-10-01
10111953 Methods for reducing remnant cholesterol and other lipoprotein fractions by administering an inhibitor of proprotein convertase subtilisin kexin-9 (PCSK9) Gary Swergold, William J. Sasiela 2018-10-30
9724411 Methods for treating hypercholesterolemia and reducing LDL-C using antibodies to PCSK9 Mark Sleeman, Joel H. Martin, Tammy T. Huang, Douglas MacDonald, Gary Swergold +1 more 2017-08-08